Anemonin suppresses sepsis‐induced acute lung injury by inactivation of nuclear factor‐kappa B and activation of nuclear factor erythroid 2‐related factor‐2/heme oxygenase‐1 pathway
The FASEB Journal · 31.01.2025 · 39 (2)
DOI: 10.1096/fj.202401987rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 18.01.2025. Verfasst von Qingping Xia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science and Education, Gaozhou People's Hospital, Maoming, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Sepsis, NF-kappa B, NF-E2-Related Factor 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Medical Research Foundation of Guangdong Province, Project of Guangdong Provincial Chinese Medicine Bureau, Special Funds for the Development of Science and Technology of Guangdong Province.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐induced acute lung injury (ALI) is a common acute and severe reason of death in the intensive care unit. Although the pathogenesis is complicated and multifactorial, elevated inflammation and oxidative stress are considered as fundamental mechanisms for the progression of ALI. Anemonin is a natural compound with diverse biological properties including anti‐inflammatory and anti‐oxidative effects. To identify whether anemonin has protective effects on sepsis‐induced ALI, a mouse sepsis‐induced ALI model and cellular models using the mouse alveolar macrophage MH‐S cells and mouse lung epithelial MLE‐12 cells were established. Our results showed that anemonin reduced lipopolysaccharide (LPS)‐induced mortality, and improved sepsis‐induced ALI in the mouse model, as shown by improved histopathological changes, decreased lung wet/dry weight ratio, and myeloperoxidase activity. Anemonin alleviated LPS‐induced secretion of tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), and interleukin‐6 (IL‐6) in bronchoalveolar lavage fluid samples, as well as reversed the LPS‐caused increase in malondialdehyde (MDA) content and decrease in activities of the antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) in lung tissues. In the cellular model, anemonin inhibited the LPS‐induced inflammatory responses and oxidative stress in MH‐S and MLE‐12 cells. In addition, anemonin inhibited LPS‐induced nuclear factor‐kappa B (NF‐κB) pathway, while enhancing the activation of nuclear factor erythroid 2‐related factor‐2 (Nrf2) in lung tissues, MH‐S, and MLE‐12 cells. NF‐κB inhibition enhanced the anti‐inflammatory and anti‐oxidative effects of anemonin, while Nrf2 knockdown attenuated these effects of anemonin, implying the critical roles of NF‐κB and Nrf2. These results indicated that anemonin suppressed sepsis‐induced acute lung injury by inhibition of NF‐κB and activation of Nrf2/heme oxygenase‐1 pathway, suggesting that anemonin might be developed as a new therapeutic agent for the treatment of sepsis‐induced ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science and Education, Gaozhou People's Hospital, Maoming, China.
- Department of Medical Imaging, Affiliated Hospital of Jilin Medical University, Jilin, China.
- Department of Anesthesiology, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Cardiovascular Surgery, Gaozhou People's Hospital, Maoming, China.
ORCID-Profile: Qingping Xia, Liangqing Zhang, Baodong Xie, Li Deng
Förderung
- Medical Research Foundation of Guangdong Province
- Project of Guangdong Provincial Chinese Medicine Bureau
- Special Funds for the Development of Science and Technology of Guangdong Province
- Guangdong provincial Engineering Technology Research Center for the Diagnosis and Treatment of Severe Cardiac Diseases
- Guangdong Medical Research Foundation
Zitieren
APA
Xia, Q., Liu, G., Zhang, L., Xie, B., & Deng, L. (2025). Anemonin suppresses sepsis‐induced acute lung injury by inactivation of nuclear factor‐kappa B and activation of nuclear factor erythroid 2‐related factor‐2/heme oxygenase‐1 pathway. The FASEB Journal, 39(2). https://doi.org/10.1096/fj.202401987rr
Vancouver
Xia Q, Liu G, Zhang L, Xie B, Deng L. Anemonin suppresses sepsis‐induced acute lung injury by inactivation of nuclear factor‐kappa B and activation of nuclear factor erythroid 2‐related factor‐2/heme oxygenase‐1 pathway. The FASEB Journal. 2025;39(2). doi:10.1096/fj.202401987rr
BibTeX
@article{Xia2025,
author = {Xia, Qingping and Liu, Guohao and Zhang, Liangqing and Xie, Baodong and Deng, Li},
title = {Anemonin suppresses sepsis‐induced acute lung injury by inactivation of nuclear factor‐kappa B and activation of nuclear factor erythroid 2‐related factor‐2/heme oxygenase‐1 pathway},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {2},
doi = {10.1096/fj.202401987rr}
}
EUVIMED